7 Item 1A. Risk Factors 38 Item 1B. Unresolved Staff Comments 64 Item 1C. Cybersecurity 64 Item 2. Properties 65 Item 3. Legal Proceedings 65 Item 4. Mine Safety Disclosures 65 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 66 Item 6. [Reserved] 67 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 68 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 81 Item 8....
Q2 FY2026 — expected 2026-09-06
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-17 | 2025-12-31 | 0001193125-26-053334 | EDGAR | 79K words |
| 2025-02-25 | 2024-12-31 | 0000950170-25-026115 | EDGAR | — |
| 2024-02-26 | 2023-12-31 | 0000950170-24-019770 | EDGAR | — |
| 2023-03-14 | 2022-12-31 | 0000950170-23-007729 | EDGAR | — |
| 2022-03-15 | 2021-12-31 | 0001564590-22-010238 | EDGAR | — |
| 2021-03-16 | 2020-12-31 | 0001564590-21-013325 | EDGAR | — |
| 2020-03-26 | 2019-12-31 | 0001564590-20-013188 | EDGAR | — |
| 2019-03-28 | 2018-12-31 | 0001193125-19-089299 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-07 | 2025-09-30 | 0001193125-25-272334 | EDGAR | 27K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-102440 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0000950170-25-064005 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124712 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091229 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0000950170-24-053977 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0000950170-23-059769 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0000950170-23-039394 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019166 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0000950170-22-024685 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000950170-22-015760 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001564590-22-019089 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-17 | 0001193125-26-053131 | EDGAR | 3K words |
| 2025-12-08 | 0001193125-25-311217 | EDGAR | — |
| 2025-11-18 | 0001193125-25-286158 | EDGAR | — |
| 2025-11-13 | 0001193125-25-278679 | EDGAR | — |
| 2025-11-10 | 0001193125-25-273315 | EDGAR | — |
| 2025-11-03 | 0001193125-25-261797 | EDGAR | — |
| 2025-09-11 | 0001193125-25-201353 | EDGAR | — |
| 2025-08-05 | 0000950170-25-102433 | EDGAR | — |
| 2025-07-10 | 0001193125-25-157390 | EDGAR | — |
| 2025-07-07 | 0001193125-25-155811 | EDGAR | — |
156 total filings indexed. 126 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001622229 |
| Ticker | COGT |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.cogentbio.com |
| Listed | 2018-03-29 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report